Some private hospitals in Delhi-NCR have started offering antibody cocktail therapy for high-risk Covid patients with mild to moderate symptoms. commonly called as ‘antibody cocktail’. It is now also available in India. Roche India and Cipla announced its launch in the country on Monday. It can be given to those people who have high risk of severe Covid disease
